T O P I C R E V I E W
***PKTX.. Dear Protokinetix Investors.. In Short, This has been the PKTX PR NEWS within the present.. Deal with it and WE are Looking Great...For the Future.. :+)
...AAGP Found to Significantly Improve Islet Cell Transplantation in Type 1 Diabetes..
...Patients ProtoKinetix’ AAGP™ to Be Presented at the Congress of the International Pancreas and Islet Transplant Association..
..ProtoKinetix Begins Testing Diabetic Mice with AAGP™ at the University of Alberta..
***PKTX...ProtoKinetix Reports on Its Strong Collaboration with the James Shapiro Laboratory at the University of Alberta
**PKTX.. ProtoKinetix Upgrades to OTCQB... OFF of Pinks..!
**PKTX..CEO Clarence Smith Reports on Edmonton Meetings with Dr. James Shapiro and his Team...
***University of Alberta...Acquisition of Patent....
***ProtoKinetix Announces Acquisition of Patents 12:26 PM ET, 04/14/2015 - Business Wire..
***ProtoKinetix Announces Acquisition of Patents..
***University of Alberta Diabetes Institute Encouraged by Preliminary Results of Testing of ProtoKinetix Licensed AAGP™ Molecule in Islet Cell Transplantation..